Fingerprint
Dive into the research topics of 'A phase I study of the Heat Shock Protein 90 inhibitor alvespimycin (17-DMAG) given intravenously to patients with advanced, solid tumours.'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically